About Cardiokine
Cardiokine is a company based in Philadelphia (United States) founded in 2003 was acquired by Cornerstone Therapeutics in January 2012.. Cardiokine has raised $87 million across 2 funding rounds from investors including Eight Roads Ventures, Burrill and Company and Cornerstone Therapeutics. Cardiokine operates in a competitive market with competitors including Tenaya Therapeutics, Cellino, MyoKardia, Eiger BioPharmaceuticals and Arrakis Therapeutics, among others.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cardiokine, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$87 M (USD)
in 2 rounds
-
Latest Funding Round
$50 M (USD), Series B
May 01, 2006
-
Investors
Eight Roads Ventures
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Cornerstone Therapeutics
(Jan 04, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cardiokine
Cardiokine has successfully raised a total of $87M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $50 million completed in May 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $50.0M
-
First Round
First Round
(13 Apr 2004)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2006 | Amount | Series B - Cardiokine | Valuation |
investors |
|
| Apr, 2004 | Amount | Series A - Cardiokine | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cardiokine
Cardiokine has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Eight Roads Ventures, Burrill and Company and Cornerstone Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investment and global platform support for startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cardiokine
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cardiokine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cardiokine Comparisons
Competitors of Cardiokine
Cardiokine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tenaya Therapeutics, Cellino, MyoKardia, Eiger BioPharmaceuticals and Arrakis Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Specialized drugs are developed for genetic heart diseases.
|
|
| domain | founded_year | HQ Location |
Developer of antiviral agents against targets in the treatment of hepatitis
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
|
| domain | founded_year | HQ Location |
Regenerative medicine for cardiovascular disorders is developed using cell-based platforms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cardiokine
When was Cardiokine founded?
Cardiokine was founded in 2003 and raised its 1st funding round 1 year after it was founded.
Where is Cardiokine located?
Cardiokine is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Is Cardiokine a funded company?
Cardiokine is a funded company, having raised a total of $87M across 2 funding rounds to date. The company's 1st funding round was a Series A of $37M, raised on Apr 13, 2004.
What does Cardiokine do?
Cardiokine was founded in 2003 in Philadelphia, United States, operating as a specialty pharmaceutical firm. Efforts are directed toward developing treatments for cardiovascular conditions, including lixivaptan, an oral vasopressin receptor antagonist targeted at hyponatremia in congestive heart failure patients. The companys work in this sector concluded with its acquisition by Cornerstone Therapeutics in 2012.
Who are the top competitors of Cardiokine?
Cardiokine's top competitors include Esperion Therapeutics, Tenaya Therapeutics and Cellino.
Who are Cardiokine's investors?
Cardiokine has 5 investors. Key investors include Eight Roads Ventures, Burrill and Company, Cornerstone Therapeutics, Adventure Capital, and Care Capital.